Biocept, inc. reports earnings results for the third quarter ended september 30, 2019

Biocept, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced sales was usd 1.529 million compared to usd 761,591 a year ago. operating loss was usd 5.629 million compared to usd 6.007 million a year ago. net loss was usd 5.691 million compared to usd 6.047 million a year ago. basic loss per share from continuing operations was usd 0.25 compared to usd 2.42 a year ago. for the nine months, sales was usd 3.744 million compared to usd 2.390 million a year ago. operating loss was usd 17.405 million compared to usd 18.320 million a year ago. net loss was usd 19.424 million compared to usd 18.558 million a year ago. basic loss per share from continuing operations was usd 1.1 compared to usd 8.26 a year ago. diluted loss per share from continuing operations was usd 1.1 compared to usd 8.27 a year ago.
BIOC Ratings Summary
BIOC Quant Ranking